Citadel Advisors’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.9K | Sell |
54,039
-28,084
|
|
||||
|
2025
Q1 | $130K | Sell |
82,123
-76,918
|
|
||||
|
2024
Q4 | $285K | Buy |
159,041
+130,562
|
|
||||
|
2024
Q3 | $173K | Buy |
28,479
+3,354
|
|
||||
|
2024
Q2 | $132K | Sell |
25,125
-11,393
|
|
||||
|
2024
Q1 | $310K | Sell |
36,518
-227,089
|
|
||||
|
2023
Q4 | $1.74M | Buy |
263,607
+258,132
|
|
||||
|
2023
Q3 | $16.9K | Sell |
5,475
-5,408
|
|
||||
|
2023
Q2 | $29.4K | Buy |
+10,883
|
|
||||
|
2023
Q1 | – | Hold |
0
|
|
||||
|
2022
Q4 | – | Hold |
0
|
|
||||
|
2022
Q3 | – | Hold |
0
|
|
||||
|
2022
Q2 | – | Hold |
0
|
|
||||
|
2022
Q1 | – | Sell |
-483,897
|
|
||||
|
2021
Q4 | $6.87M | Sell |
483,897
-201,634
|
|
||||
|
2021
Q3 | $5.49M | Sell |
685,531
-35,170
|
|
||||
|
2021
Q2 | $20.6M | Buy |
720,701
+234,042
|
|
||||
|
2021
Q1 | $14.1M | Buy |
486,659
+85,047
|
|
||||
|
2020
Q4 | $4.79M | Sell |
401,612
-732
|
|
||||
|
2020
Q3 | $2.78M | Buy |
+402,344
|
|
||||
|
2018
Q2 | – | Sell |
-2,682
|
|
||||
|
2018
Q1 | $10K | Buy |
2,682
+603
|
|
||||
|
2017
Q4 | $9K | Sell |
2,079
-1,092
|
|
||||
|
2017
Q3 | $18K | Buy |
3,171
+2,228
|
|
||||
|
2017
Q2 | $10K | Buy |
+943
|
|